Evaluation of the APRI (AST, platelet ratio index) and ELF™ (Enhanced Liver Fibrosis) tests to detect significant fibrosis due to chronic hepatitis C

Ítems similars

• Performance of the AST to Platelet Ratio Index (APRI) as a Noninvasive Marker of Fibrosis in Pediatric Patients with Chronic Viral Hepatitis
  per: McGoogan, Katherine E., et al.
  Publicat: (2010)
• AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects
  per: De Matteis, Carlo, et al.
  Publicat: (2021)
• Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)
  per: Adler, Michael
  Publicat: (2011)
• Aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with chronic liver disease
  per: Anania, Caterina, et al.
  Publicat: (2011)
• Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease
  per: Fallatah, Hind I., et al.
  Publicat: (2016)